- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02257034
The Effect of Tai Chi in Treating Fibromyalgia
March 31, 2017 updated by: Yang Min, Chengdu PLA General Hospital
To evaluate the effect of Tai chi on Fibromyalgia
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sichuan
-
Chengdu, Sichuan, China, 610083
- General Hospital of Chengdu Military Area Command PLA
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 40 years of age or older
- meeting the classification of FM per the 1990 ACR criteria
- approval by a healthcare provider for participation
Exclusion Criteria:
- had practiced Tai chi within the past 6 months
- had exercised >30 min three times weekly for past 3 months
- could not independently ambulate without assistive devices
- had BPI pain severity or interference scores less than 5
- had planned elective surgery during study period
- were actively involved in health-related litigation
- were unwilling to keep all treatments/medications steady throughout the study period
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Taichi
patients exercise with Tai chi
|
|
Sham Comparator: Control
patients under exercise of dance
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Fibromyalgia Impact Questionnaire (FIQ)
Time Frame: up to 48 weeks
|
up to 48 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2014
Primary Completion (Anticipated)
December 1, 2022
Study Completion (Anticipated)
December 1, 2022
Study Registration Dates
First Submitted
October 2, 2014
First Submitted That Met QC Criteria
October 3, 2014
First Posted (Estimate)
October 6, 2014
Study Record Updates
Last Update Posted (Actual)
April 4, 2017
Last Update Submitted That Met QC Criteria
March 31, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TC20140601
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
University of AberdeenCompletedFibromyalgia | Fibromyalgia, Primary | Fibromyalgia, SecondaryUnited Kingdom
-
Eli Lilly and CompanyCompletedFibromyalgia, Primary | Fibromyalgia, SecondaryMexico
-
Rasmia ElgoharyNot yet recruiting
-
Tel-Aviv Sourasky Medical CenterCompletedFibromyalgia (FM)Israel
-
Yousra Hisham Abdel FattahCompletedFibromyalgia, PrimaryEgypt
-
Forest LaboratoriesCypress Bioscience, Inc.TerminatedPrimary FibromyalgiaUnited States
-
Universidade Federal do Rio Grande do NorteCompleted
-
Tonix Pharmaceuticals, Inc.CompletedPrimary FibromyalgiaUnited States
-
Tonix Pharmaceuticals, Inc.CompletedPrimary FibromyalgiaUnited States
-
University of ManitobaCompleted
Clinical Trials on Taichi
-
Beijing Sport UniversityCompletedCardiovascular Diseases | Hypertension | Sleep Disorder | Cognitive Impairment | Metabolic DiseaseChina
-
Heilongjiang University of Chinese MedicineUnknownPolycystic Ovary SyndromeChina
-
Universiti Putra MalaysiaRecruitingPhysical Inactivity | Mental Health IssueChina
-
Universidade do PortoCompleted
-
Sheba Medical CenterTel Aviv UniversityWithdrawnOvarian Cancer | Primary Peritoneal Cancer | Other Gynecological CancersIsrael
-
Northeast Normal UniversityCompleted
-
Hugo W. Moser Research Institute at Kennedy Krieger...Suspended
-
Hugo W. Moser Research Institute at Kennedy Krieger...Active, not recruiting